Reinhard Busse

Q: What Schools Are Affiliated With Reinhard Busse

Reinhard Busse is affiliated with the following schools: University of Marburg, University of Cologne, Hannover Medical School, Technical University of Berlin

Reinhard Busse's AcademicInfluence.com Rankings

Reinhard Busse

Economics

#2320

World Rank

#2654

Historical Rank

economics Degrees

Download Badge

Economics

Reinhard Busse's Degrees

PhD Health Economics University of Cologne
Masters Health Economics University of Cologne

Why Is Reinhard Busse Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Reinhard Busse is a German physician and health economist. He is a university professor at the Technical University of Berlin, where he has, since 2002, headed the Department of Healthcare Management at the Faculty of Economics and Management.

(See a Problem?)

Reinhard Busse's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (5789)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) (4169)
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (3308)
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (2239)
Nurses' reports on hospital care in five countries. (2001) (1752)
Patient safety, satisfaction, and quality of hospital care: cross sectional surveys of nurses and patients in 12 countries in Europe and the United States (2012) (1627)
Nurse staffing and education and hospital mortality in nine European countries: a retrospective observational study (2014) (1566)
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (1515)
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study (2020) (563)
Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (538)
Diagnosis related groups in Europe: moving towards transparency, efficiency, and quality in hospitals? (2013) (517)
Prevalence, patterns and predictors of nursing care left undone in European hospitals: results from the multicountry cross-sectional RN4CAST study (2013) (441)
Germany: Health system review. (2014) (381)
Tackling Chronic Disease in Europe: Strategies, Interventions and Challenges (2010) (355)
Nurse forecasting in Europe (RN4CAST): Rationale, design and methodology (2011) (333)
Five insights from the Global Burden of Disease Study 2019 (2020) (291)
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) (279)
Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. (2000) (256)
A systematic survey instrument translation process for multi-country, comparative health workforce studies. (2013) (206)
Methods to determine reimbursement rates for diagnosis related groups (DRG): A comparison of nine European countries (2006) (202)
Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition (2017) (197)
Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050 (2019) (195)
Disease management programs in Germany's statutory health insurance system. (2004) (190)
Poland health system review. (2011) (187)
Social Health Insurance Systems in Western Europe (2004) (164)
A comparison of hospital administrative costs in eight nations: US costs exceed all others by far. (2014) (163)
Health Care Systems in Transition (2002) (155)
Mapping 123 million neonatal, infant and child deaths between 2000 and 2017 (2019) (140)
European network for Health Technology Assessment, EUnetHTA: Planning, development, and implementation of a sustainable European network for Health Technology Assessment (2009) (131)
Improving healthcare quality in Europe: Characteristics, effectiveness and implementation of different strategies (2019) (128)
The SELFIE framework for integrated care for multi-morbidity: Development and description. (2017) (124)
The COVID-19 vaccines rush: participatory community engagement matters more than ever (2020) (122)
What is 'best practice' in health care? State of the art and perspectives in improving the effectiveness and efficiency of the European health care systems. (2001) (121)
The effects of gatekeeping: A systematic review of the literature (2011) (121)
Paying for hospital care: the experience with implementing activity-based funding in five European countries (2012) (118)
Nurses in advanced roles in primary care: Policy levers for implementation (2017) (114)
Editorial: Hospital case payment systems in Europe (2006) (113)
Regulating entrepreneurial behaviour in European health care systems (2002) (112)
Leadership and governance in seven developed health systems. (2012) (112)
Cost accounting to determine prices: How well do prices reflect costs in the German DRG-system? (2006) (111)
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019 (2021) (108)
Hospital ownership and efficiency: a review of studies with particular focus on Germany. (2012) (108)
Integrated care experiences and outcomes in Germany, the Netherlands, and England. (2014) (107)
Variability in healthcare treatment costs amongst nine EU countries - results from the HealthBASKET project. (2008) (105)
Mental health in Vietnam: Burden of disease and availability of services. (2011) (102)
A Framework for Health System Comparisons: The Health Systems in Transition (HiT) Series of the European Observatory on Health Systems and Policies (2019) (101)
Ethical issues in funding orphan drug research and development (2005) (96)
Disease management programs for type 2 diabetes in Germany: a systematic literature review evaluating effectiveness. (2014) (94)
Statutory health insurance competition in Europe: a four-country comparison. (2013) (93)
Use of acute hospital beds does not increase as the population ages: results from a seven year cohort study in Germany (2002) (92)
Defining the “Health Benefit Basket” in nine European countries (2005) (91)
Health technology assessment : an introduction to objectives, role of evidence, and structure in Europe (2005) (88)
Major differences in ICU admissions during the first and second COVID-19 wave in Germany (2021) (86)
Relevant models and elements of integrated care for multi-morbidity: Results of a scoping review. (2018) (86)
Descriptive, cross-country analysis of the nurse practitioner workforce in six countries: size, growth, physician substitution potential (2016) (82)
Measuring, monitoring, and managing quality in Germany's hospitals. (2009) (82)
Pharmaceutical regulation in 15 European countries review. (2016) (81)
DRG-based hospital payment systems and technological innovation in 12 European countries. (2011) (80)
Health care cost containment strategies used in four other high-income countries hold lessons for the United States. (2013) (79)
Hospital payment based on diagnosis-related groups differs in Europe and holds lessons for the United States. (2013) (77)
Balancing adoption and affordability of medical devices in Europe. (2009) (77)
Developing Health Technology Assessment to address health care system needs. (2010) (75)
Health care reform in Germany: patchwork change within established governance structures. (2005) (75)
Assessing the effectiveness of strategies to implement clinical guidelines for the management of chronic diseases at primary care level in EU Member States: a systematic review. (2012) (75)
Ginkgo biloba in Alzheimer’s disease: a systematic review (2010) (74)
Analysing the impact of health-care system change in the EU member states--Germany. (2005) (73)
Systematic review of the methodological quality of clinical guideline development for the management of chronic disease in Europe. (2012) (69)
Costs and effects of new professional roles: Evidence from a literature review. (2015) (67)
Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3 (2020) (60)
Strengthening health systems through nursing: Evidence from 14 European countries (2019) (58)
Clinical guidelines in the European Union: mapping the regulatory basis, development, quality control, implementation and evaluation across member states. (2012) (57)
Regulation of pharmaceutical markets in Germany: improving efficiency and controlling expenditures? (2005) (56)
Management im Gesundheitswesen (2006) (51)
Nurse migration in Europe--can expectations really be met? Combining qualitative and quantitative data from Germany and eight of its destination and source countries. (2013) (50)
Strategic purchasing to improve health system performance: key issues and international trends. (2007) (50)
Methods for the comparative evaluation of pharmaceuticals (2005) (49)
Social health insurance (2002) (48)
Hospital case payment systems in Europe. (2006) (48)
Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction: the reality of care revealed by claims data analysis. (2011) (48)
Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund. (2009) (48)
Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 (2020) (47)
6-month mortality and readmissions of hospitalized COVID-19 patients: A nationwide cohort study of 8,679 patients in Germany. (2021) (46)
Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050 (2021) (46)
The impact of physician supply on avoidable cancer deaths in Germany. A spatial analysis. (2011) (46)
Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies. (2003) (44)
Analyzing changes in health financing arrangements in high-income countries : a comprehensive framework approach (2007) (44)
Do diagnosis-related groups explain variations in hospital costs and length of stay? Analyses from the EuroDRG project for 10 episodes of care across 10 European countries. (2012) (44)
The introduction of DRG funding and hospital nurses' changing perceptions of their practice environment, quality of care and satisfaction: comparison of cross-sectional surveys over a 10-year period. (2013) (43)
The road to reform (2005) (43)
How can the impact of health technology assessments be enhanced (2008) (42)
Structural changes in the German pharmaceutical market: price setting mechanisms based on the early benefit evaluation. (2013) (42)
Implizite Rationierung von Pflegeleistungen in deutschen Akutkrankenhäusern – Ergebnisse der internationalen Pflegestudie RN4Cast (2014) (41)
Appendectomy and diagnosis-related groups (DRGs): patient classification and hospital reimbursement in 11 European countries (2011) (39)
Task shifting between physicians and nurses in acute care hospitals: cross-sectional study in nine countries (2018) (39)
Cross-border healthcare in the European Union: clarifying patients’ rights (2011) (38)
Analysing arrangements for cross-border mobility of patients in the European Union: a proposal for a framework. (2012) (37)
From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries (2015) (37)
chapter two Introduction to DRGs in Europe : Common objectives across different hospital systems (2013) (37)
Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study (2022) (37)
Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer's perspective: Stereotactic radiosurgery versus surgical resection (2013) (37)
Cross-cultural evaluation of the relevance of the HCAHPS survey in five European countries. (2012) (36)
HTA of medical devices: Challenges and ideas for the future from a European perspective. (2017) (36)
The European union and health services : the impact of the single European market on member states (2002) (35)
Optimising antimicrobial use in humans – review of current evidence and an interdisciplinary consensus on key priorities for research (2021) (35)
Priority-setting and rationing in German health care. (1999) (34)
Mobility of health professionals pre and post 2004 and 2007 EU enlargements: evidence from the EU project PROMeTHEUS. (2012) (34)
Assessing the responsiveness of chronic disease care - is the World Health Organization's concept of health system responsiveness applicable? (2014) (34)
Determining the “Health Benefit Basket” of the Statutory Health Insurance scheme in Germany (2005) (34)
Licensing procedures and registration of medical doctors in the European Union. (2014) (34)
Methodological considerations when translating “burnout”☆ (2014) (32)
Instruments to measure outcomes of post-intensive care syndrome in outpatient care settings – Results of an expert consensus and feasibility field test (2020) (32)
Comparison of hospital costs and length of stay associated with open-mesh, totally extraperitoneal inguinal hernia repair, and transabdominal preperitoneal inguinal hernia repair: An analysis of observational data using propensity score matching (2013) (31)
Determinants of hospital costs and performance variation : Methods , models and variables for the EuroDRG project (2010) (31)
Paying for chronic disease care (2008) (31)
Policy Brief: Cross-Border Health Care in Europe (2005) (31)
Evaluating the Impact of an Accountable Care Organization on Population Health: The Quasi-Experimental Design of the German Gesundes Kinzigtal. (2017) (30)
Financing reforms in the German hospital sector: from full cost cover principle to prospective case fees. (1997) (29)
The wider determinants of inequalities in health: a decomposition analysis (2011) (29)
Regionale Unterschiede der Lebenserwartung in Deutschland auf Ebene der Kreise und kreisfreien Städte und deren möglichen Determinanten (2011) (28)
Mapping health services access: National and cross border issues (HealthAccess) Final report. (2007) (27)
[Nursing tasks left undone in German acute care hospitals - results from the international study RN4Cast]. (2014) (27)
Classification of hospital admissions into emergency and elective care: a machine learning approach (2019) (27)
Breast cancer surgery and diagnosis-related groups (DRGs): patient classification and hospital reimbursement in 11 European countries. (2013) (27)
Measuring, Reporting, and Rewarding Quality of Care in 5 Nations: 5 Policy Levers to Enhance Hospital Quality Accountability (2017) (27)
The ABC of DRGs (2009) (26)
Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care. (2006) (26)
Health target programmes and health care services--any link?: a conceptual and comparative study (part 1). (2002) (26)
Temporal trends of cancer incidence in Vietnam, 1993-2007. (2010) (25)
Benchmarking der Krankenhaus-IT: Deutschland im internationalen Vergleich (2019) (25)
How do medical doctors in the European Union demonstrate that they continue to meet criteria for registration and licencing? (2014) (25)
The new regulation to investigate potentially beneficial diagnostic and therapeutic methods in Germany: up to international standard? (2014) (25)
Chronic disease management in Europe (2009) (25)
Outcome-related health targets--political strategies for better health outcomes: a conceptual and comparative study (part 2). (2002) (25)
Risk structure compensation in Germany's statutory health insurance. (2001) (25)
Acute myocardial infarction and diagnosis-related groups: patient classification and hospital reimbursement in 11 European countries (2013) (25)
Different spreading dynamics throughout Germany during the second wave of the COVID-19 pandemic: a time series study based on national surveillance data (2021) (24)
Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (23)
Paying hospital specialists: Experiences and lessons from eight high-income countries. (2018) (23)
Lean manufacturing and Toyota Production System terminology applied to the procurement of vascular stents in interventional radiology (2011) (23)
HEALTH TECHNOLOGY ASSESSMENT OF MEDICAL DEVICES IN EUROPE: PROCESSES, PRACTICES, AND METHODS (2016) (23)
Health workforce planning: which countries include nurse practitioners and physician assistants and to what effect? (2018) (23)
Extracranial metastatic patterns on occurrence of brain metastases (2011) (23)
Hospitalisation Costs of Cystic Fibrosis (2012) (22)
Patients' perceptions of health system responsiveness in ambulatory care in Germany. (2019) (22)
The UK needs a sustainable strategy for COVID-19 (2020) (22)
DRG-type hospital payment in Germany : The G-DRG system (2010) (22)
Health systems in transition: template for analysis (2007) (22)
Cross-Country Comparisons of Costs: The Use of Episode-Specific Transitive Purchasing Power Parities with Standardised Cost Categories (2008) (22)
Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure (2021) (22)
Methoden zur vergleichenden Bewertung pharmazeutischer Produkte (2005) (22)
Ein valides Instrument zur Messung der Patientenzufriedenheit in ambulanter haus- und fachärztlicher Behandlung: das Qualiskope-A (2004) (21)
The cost-effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of brain metastasis in Vietnam from the perspective of patients and families. (2012) (20)
Leistungsmanagement in der Integrierten Versorgung (2006) (20)
Exploring Health System Responsiveness in Ambulatory Care and Disease Management and its Relation to Other Dimensions of Health System Performance (RAC) - Study Design and Methodology. (2015) (20)
Forgone care among chronically ill patients in Germany-Results from a cross-sectional survey with 15,565 individuals. (2016) (20)
Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17 (2020) (20)
Regulating Quality and Safety of Health and Social Care: International Experiences. (2014) (19)
Diabetes-Surveillance in Deutschland – Auswahl und Definition von Indikatoren (2018) (19)
Pricing behaviour of pharmacies after market deregulation for OTC drugs: the case of Germany. (2007) (19)
How to meet the challenge of ageing populations (2011) (19)
Clinical guidelines for chronic conditions in the European Union (2013) (19)
Regulation of health-related technologies in Germany. (1999) (19)
Extrabudgetary ('NUB') payments: A gateway for introducing new medical devices into the German inpatient reimbursement system? (2010) (19)
Health-care improvements in a financially constrained environment (2016) (19)
Cystic fibrosis (2012) (19)
12‐hr shifts in nursing: Do they remove unproductive time and information loss or do they reduce education and discussion opportunities for nurses? A cross‐sectional study in 12 European countries (2019) (19)
Health care public reporting utilization – user clusters, web trails, and usage barriers on Germany’s public reporting portal Weisse-Liste.de (2017) (18)
Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry? (2018) (18)
Macht der Hausarzt als Lotse die Gesundheitsversorgung wirklich besser und billiger? Ein systematischer Review zum Konzept Gatekeeping (2010) (18)
A country-level analysis comparing hospital capacity and utilisation during the first COVID-19 wave across Europe (2021) (18)
Cost-sharing in the German health care system (2004) (18)
Hospital quality variation matters - A time-trend and cross-section analysis of outcomes in German hospitals from 2006 to 2014. (2017) (18)
Length of Psychiatric Inpatient Stay : Comparison of Mental Health Care Outlining a Case Mix From a Hospital in Germany and the United States of America (2008) (17)
Stroke units, certification, and outcomes in German hospitals: a longitudinal study of patient-based 30-day mortality for 2006–2014 (2018) (17)
Patient-level hospital costs and length of stay after conventional versus minimally invasive total hip replacement: a propensity-matched analysis. (2012) (17)
Wissenschaftliches Gutachten für die Auswahl von 50 bis 80 Krankheiten zur Berücksichtigung im morbiditätsorientierten Risikostrukturausgleich (2007) (16)
HEALTH TECHNOLOGY ASSESSMENT IN GERMANY (2000) (16)
Nurses' Reports On Hospital Care In Five (2001) (16)
Comparing routine administrative data with registry data for assessing quality of hospital care in patients with myocardial infarction using deterministic record linkage (2016) (16)
Internationale Standards der Kosten-Nutzen-Bewertung (2006) (16)
Building European reference networks in health care : exploring concepts and national practices in the European Union (2013) (15)
CARDIAC CATHETERIZATION IN GERMANY (1999) (15)
Healthcare financing in Syria: satisfaction with the current system and the role of national health insurance--a qualitative study of householders' views. (2012) (15)
Heterogeneity of European DRG systems and potentials for a common EuroDRG system Comment on "Cholecystectomy and Diagnosis-Related Groups (DRGs): patient classification and hospital reimbursement in 11 European countries". (2015) (15)
Published and unpublished evidence in coverage decision-making for pharmaceuticals in Europe: existing approaches and way forward (2016) (15)
TAXONOMY OF MEDICAL DEVICES IN THE LOGIC OF HEALTH TECHNOLOGY ASSESSMENT (2015) (15)
Complementary and alternative medicine in the UK and Germany - research and evidence on supply and demand (2003) (15)
Effectiveness and Cost of Atypical Versus Typical Antipsychotic Treatment in a Nationwide Cohort of Patients With Schizophrenia in Germany (2012) (15)
Determining the “Health Benefit Basket” of the Statutory Health Insurance scheme in Germany (2005) (14)
Ärztliche Einstellungen gegenüber Leitlinien : Eine empirische Untersuchung In neurologischen Kliniken (2005) (14)
Vermeidbare Sterbefälle in Deutschland: Räumliche Verteilung und regionale Konzentrationen (2011) (14)
Learning From the European Experience of Using Targets to Improve Population Health (2010) (14)
Leistungsmanagement in Krankenhäusern (2006) (14)
Arzneimittelfestbeträge: Gruppenbildung, Preisberechnung mittels Regressionsverfahren und Wirkungen (2005) (14)
The iMpact on practice, oUtcomes and costs of New roles for health pROfeSsionals: a study protocol for MUNROS (2016) (14)
Low demand for substitutive voluntary health insurance in Germany. (2002) (14)
Medizin und Ökonomie: Maßnahmen für eine wissenschaftlich begründete, patientenzentrierte und ressourcenbewusste Versorgung. Ein Strategiepapier der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2019) (14)
How to strengthen financing mechanism to promote care for people with multimorbidity in Europe (2017) (14)
Drawing light from the pandemic: Rethinking strategies for health policy and beyond (2021) (13)
Arzneimittelversorgung in der GKV und 15 anderen europäischen Gesundheitssystemen (2015) (13)
Das deutsche Gesundheitssystem: Akteure, Daten, Analysen (2017) (13)
CONSIDERING EQUITY IN HEALTH TECHNOLOGY ASSESSMENT: AN EXPLORATORY ANALYSIS OF AGENCY PRACTICES (2015) (13)
Expenditure on health care in the EU: making projections for the future based on the past (2001) (13)
Improving Healthcare Quality in Europe (2019) (13)
Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany (2012) (13)
Shaping the Societal Bill: past and future trends in education, pensions and healthcare expenditure (2003) (12)
chapter fourteen Germany : Understanding G-DRGs (2013) (12)
New professional roles and patient satisfaction: Evidence from a European survey along three clinical pathways. (2018) (12)
Informed consumer or unlucky visitor? A profile of German patients who received dental services abroad. (2015) (12)
Achieving Sustainability and Scale-Up of Mobile Health Noncommunicable Disease Interventions in Sub-Saharan Africa: Views of Policy Makers in Ghana (2019) (12)
Evidence-based indications for the planning of PET or PET/CT capacities are needed (2019) (12)
Access to health care in the EU Member States (2006) (12)
Die Einführung der Praxisgebühr und ihre Wirkung auf die Zahl der Arztkontakte und die Kontaktfrequenz: eine empirische Analyse (2005) (12)
Sentinel practices in evaluating longer periods of care: quality of life and drug therapy of terminally ill persons in Lower Saxony (Germany). (1998) (12)
Mapping research on health systems in Europe: A bibliometric assessment (2011) (12)
HOW HEALTH TECHNOLOGY ASSESSMENT AGENCIES ADDRESS THE ISSUE OF UNPUBLISHED DATA (2014) (11)
Mistletoe treatments for minimising side effects of anticancer chemotherapy (2006) (11)
Apples and oranges: international comparisons of COVID-19 observational studies in ICUs (2020) (11)
Nurse staffi ng and education and hospital mortality in nine European countries : a retrospective observational study (2014) (11)
From evidence assessments to coverage decisions?: the case example of glinides in Germany. (2012) (11)
Major health reforms in 31 high-income countries in 2018 and 2019; expert informed identification, clustering, and analyses over time of "top-three" national reforms (2021) (11)
Identification of health baskets in nine EU countries (2006) (11)
Border-crossing patients in the EU (2002) (11)
"Best Practice" im Gesundheitswesen--oder warum wir evidenzbasierte Medizin, Leitlinien und Health Technology Assessment brauchen. (2000) (11)
Medical savings accounts: Singapore’s non-solution to healthcare costs (2013) (11)
Continuity of care in the cross-border context: insights from a survey of German patients treated abroad. (2015) (11)
Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations? (2021) (11)
Process mapping of PTA and stent placement in a university hospital interventional radiology department (2012) (10)
[Do primary care physicians acting as gatekeepers really improve health outcomes and decrease costs? A systematic review of the concept gatekeeping]. (2010) (10)
Acute Appendicitis: Trends in Surgical Treatment-A Population-Based Study of Over 800 000 Patients. (2021) (10)
Selecting and defining indicators for diabetes surveillance in Germany (2018) (10)
[Endoscopic polypectomy in the upper gastrointestinal tract]. (1975) (10)
Identifizierung geeigneter Versichertengruppen für die integrierte Versorgung anhand von GKV-Routinedaten (2005) (10)
Scientific Evidence in Health Technology Assessment Reports: An In-Depth Analysis of European Assessments on High-Risk Medical Devices. (2017) (10)
chapter three Understanding DRGs and DRG-based hospital payment in Europe (2013) (10)
Universal private health insurance in the Netherlands: The first year (2008) (10)
Geographic variation in health care--a special issue on the 40th anniversary of "Small area variation in health care delivery". (2014) (10)
Enhanced Recovery after Intensive Care (ERIC): study protocol for a German stepped wedge cluster randomised controlled trial to evaluate the effectiveness of a critical care telehealth program on process quality and functional outcomes (2020) (10)
Health targets and (good) governance (2006) (10)
[DRG systems in Europe. Incentives, purposes and differences in 12 countries]. (2012) (9)
Coronary stents and the uptake of new medical devices in the German system of inpatient reimbursement. (2010) (9)
Drug Budgets and Effects on Physicians' Prescription Behaviour: New Evidence from Germany (2005) (9)
Health Care Systems and Policies (2017) (9)
Verhaltensänderung durch Einführung der Praxisgebühr und Ursachenforschung (2006) (9)
CT-guided biopsies: quality, complications and impact on treatment: a retrospective initial quality control. (2011) (9)
Cost-effectiveness analysis of telemedical devices for pre-clinical traffic accident emergency rescue in Germany. (2006) (9)
Spatial distribution of avoidable cancer deaths in Germany (2012) (9)
Ökonomische Erfolgsmessung von integrierten Versorgungsnetzen – Gütekriterien, Herausforderungen, Best-Practice-Modell (2014) (9)
Health system responsiveness and chronic disease care - What is the role of disease management programs? An analysis based on cross-sectional survey and administrative claims data. (2017) (9)
Die aktuelle Situation der stationären Krankenpflege in Deutschland (2017) (9)
For-Profit Hospitals Have Thrived Because of Generous Public Reimbursement Schemes, Not Greater Efficiency: A Multi-Country Case Study (2020) (8)
[Do German DRGs appropriately explain the resource consumption of hospitals? An empirical patient-level cost-data analysis across ten episodes of care]. (2014) (8)
[Deterministic record linkage with indirect identifiers: data of the Berlin Myocardial Infarction Registry and the AOK Nordost for patients with myocardial infarction]. (2015) (8)
What are the motivating and hindering factors for health professionals to undertake new roles in hospitals? A study among physicians, nurses and managers looking at breast cancer and acute myocardial infarction care in nine countries. (2018) (8)
The European Union and Health services: Summary (2002) (8)
The use of digitally collected patient-reported outcome measures for newly operated patients with total knee and hip replacements to improve post-treatment recovery: study protocol for a randomized controlled trial (2020) (8)
[A validated questionnaire for measuring patient satisfaction in general and specialist ambulatory medical care: the Qualiskope-A]. (2004) (8)
Determining the impacts of hospital cost-sharing on the uninsured near-poor households in Vietnam (2014) (8)
Selective enrollment in Disease Management Programs for coronary heart disease in Germany – An analysis based on cross-sectional survey and administrative claims data (2017) (8)
Deciding when physicians are unfit to practise: an analysis of responsibilities, policy and practice in 11 European Union member states. (2015) (8)
Management im Gesundheitswesen – eine Einführung in Gebiet und Buch (2010) (8)
Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 (2022) (8)
Cross-border healthcare in Europe: clarifying patients' rights (2011) (8)
Obstacles to the recognition of medical prescriptions issued in one EU country and presented in another. (2013) (8)
Clinical Practice Guidelines as a quality strategy (2019) (8)
CROSS-BORDERHEALTHCARE COLLABORATIONINTHE EUROPEANUNION: PLACING THE PATIENT AT THE CENTRE (2013) (7)
Capturing modelled and perceived spatial access to ambulatory health care services in rural and urban areas in Germany. (2020) (7)
Cost-sharing in the German healthcare system: Effects of health reforms on efficiency and equity (2009) (7)
Können deutsche DRGs den Ressourcenverbrauch eines Krankenhauses sachgerecht abbilden? Eine empirische Analyse auf Grundlage von patientenbezogenen Kosten- und Leistungsdaten für 10 Krankheitsbilder (2013) (7)
Policies for disease prevention in Germany in the European context: a comparative analysis. (2004) (7)
Deterministisches Record Linkage mit indirekten Identifikatoren: Daten des Berliner Herzinfarktregisters und der AOK Nordost zum Herzinfarkt (2015) (7)
Canada: Focus on a country's health system with provincial diversity. (2016) (7)
Philippines' National Health Insurance Act (1997) (7)
[Health economics. Objectives, methodology, relevance]. (2006) (7)
Pay-for-performance: Time to act but also to provide further evidence. (2016) (7)
Regulating Long-Term Care Quality: Monitoring the quality of long-term care in Germany (2014) (7)
Internationale Erfahrungen bei der Kosten-Nutzen-Bewertung: Eine Übersicht (2009) (7)
Die Nutzenbewertung von nichtmedikamentösen Untersuchungs- und Behandlungsmethoden (2016) (7)
HEALTH TECHNOLOGY ASSESSMENT IM INTERNATIONALEN KONTEXT : WO STEHT DEUTSCHLAND? (1999) (7)
DRG-type hospital payment systems in Europe: the German G-DRG system and English Health Care Resource Groups (HRGs) (2011) (7)
chapter ten Moving towards transparency , effi ciency and quality in hospitals : Conclusions and recommendations (2013) (7)
Evidence-based decision-making for diagnostic and therapeutic methods: the changing landscape of assessment approaches in Germany (2017) (7)
Zur Strategieanfälligkeit der Arzneimittelkomponente des IPHCC + RxGroups-Klassifikationssystems in einem morbiditätsorientierten Risikostrukturausgleich - : Eine konzeptionelle und datengestützte Analyse (2007) (7)
Nurse forecasting in Europe (RN4CAST) (2011) (7)
[Cost comparison of hospital and ambulatory i.v. therapy in adult cystic fibrosis patients. Results of a controlled prospective study]. (1999) (6)
Leistungsmanagement von Krankenversicherungen (2006) (6)
Rechtliche Rahmenbedingungen in der präklinischen Notfallversorgung (2017) (6)
EVALUATION OF PREVENTIVE TECHNOLOGIES IN GERMANY (2001) (6)
[Medicine and Economy: Measures for a Science Based, Patient-Centred and Resource Conscious Care. The Association of Scientific Medical Societies' (AWMF) Strategy Paper]. (2019) (6)
Integrating the Population Perspective into Health System Performance Assessment (IPHA): Study Protocol for a Cross-Sectional Study in Germany Linking Survey and Claims Data of Statutorily and Privately Insured (2020) (6)
[The impact of co-payments on patient behavior: evidence from a natural experiment]. (2006) (6)
Health reform monitor--the impact of the financial crisis. (2012) (6)
[Turnaround time for reporting results of radiological examinations in intensive care unit patients: an internal quality control]. (2013) (6)
Targets for health in Germany (2000) (6)
Health services research in Europe: what about an open marriage? (2011) (6)
Gesundheitssysteme als epidemiologischer Gegenstand – oder: Wie wissen wir, wie effektiv Gesundheitssysteme sind? (2006) (6)
Focus on prevention, health and aging, new health professions (2007) (6)
[Pharmaceutical reference pricing in Germany: definition of therapeutic groups, price setting through regression procedure and effects]. (2005) (6)
"Top-Three" health reforms in 31 high-income countries in 2018 and 2019: an expert informed overview. (2021) (5)
Is there enough research output of EU projects available to assess and improve health system performance? An attempt to understand and categorise the output of EU projects conducted between 2002 and 2012 (2017) (5)
‘Know before you go’: information-seeking behaviour of German patients receiving health services abroad in light of the provisions of Directive 2011/24/EU (2015) (5)
Testing a new taxonomic model for the assessment of medical devices: Is it plausible and applicable? Insights from HTA reports and interviews with HTA institutions in Europe. (2019) (5)
Medical ethics in the Anthropocene: how are €100 billion of German physicians' pension funds invested? (2019) (5)
Leitlinienkonformes Praxiswissen am Beispiel Schlaganfall (2006) (5)
[Regional differences in life expectancy in Germany at county levels and their possible determinants]. (2011) (5)
Mapping research activity on mental health disorders in Europe: study protocol for the Mapping_NCD project (2016) (5)
["Best practice" in health care--or why we need evidence-based medicine, guidelines and health technology assessment]. (2000) (5)
Managing pharmaceutical regulation in Germany: Overview and economic assessment (2004) (5)
Präventionspolitik im europäischen Vergleich (2004) (5)
Targets for health: uses and abuses (2008) (5)
The Philippines' National Health Insurance Act: a German perspective. (1997) (5)
The reimbursement of new medical technologies in German inpatient care: What factors explain which hospitals receive innovation payments? (2019) (5)
[Problem-based learning in a social medicine course--a concept for improving learning achievement and practice relevance]. (1996) (5)
Effects of Activity-Based Hospital Payments in Israel: A Qualitative Evaluation Focusing on the Perspectives of Hospital Managers and Physicians (2020) (5)
The use of cost accounting methodologies to determine prices in German health care (2005) (5)
Health Systems in Transition. Pharmaceutical regulation in 15 European countries: review. (2016) (5)
Rabies mortality and morbidity associated with animal bites in Africa: a case for integrated rabies disease surveillance, prevention and control: a scoping review (2020) (5)
Health Policy's future course. (2011) (5)
The 2010 expansion of activity-based hospital payment in Israel: an evaluation of effects at the ward level (2019) (5)
Determinants of hospital costs and performance variation (2010) (5)
Cross-country comparative research - Lessons from advancing health system and policy research on the occasion of the European Observatory on Health Systems and Policies' 20th anniversary. (2018) (5)
Priorisierung in anderen Gesundheitssystemen (2010) (5)
New citizens: east Germans in a united Germany. (2004) (5)
Finanzielle Selbstbeteiligung der Patienten in Deutschland – Kaum empirische Evidenz (2004) (5)
Prehabilitation of elderly frail or pre-frail patients prior to elective surgery (PRAEP-GO): study protocol for a randomized, controlled, outcome assessor-blinded trial (2022) (4)
[Physicians' attitudes concerning guidelines. An empirical survey in neurologic clinics]. (2005) (4)
Europäischer Preisvergleich für patentgeschützte Arzneimittel (2016) (4)
Kostenvergleichsanalyse der stationären und ambulanten Intervalltherapie bei erwachsenen Mukoviszidosepatienten (1999) (4)
[Competition in healthcare--a health systems' perspective]. (2009) (4)
Wettbewerb im Gesundheitswesen – eine Gesundheitssystemperspektive (2009) (4)
[Priority setting in healthcare. What can Germany learn from other countries?]. (2010) (4)
Recognition of pharmaceutical prescriptions across the European Union: a comparison of five Member States' policies and practices. (2014) (4)
[Association between Safety Culture and Risk of Burnout: A Survey of Non-Medical Rescue Workers]. (2020) (4)
Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies (2019) (4)
Methods in health systems and policy research. (2012) (4)
Performance of reimbursement schemes in valuation of technologies: the example of magnetic resonance imaging. (2008) (4)
Regulating entrepreneurial behaviour in health care markets (2002) (4)
Defining benefit catalogues and entitlements to health care in Germany: Decision makers, decision criteria and taxonomy of catalogues (2005) (4)
How do Chronically Ill Patients Rate Medical Care by their GPs and Specialists? Results of a Germany-wide Survey. (2016) (4)
Implementation of innovative medical technologies in German inpatient care: patterns of utilization and evidence development (2021) (4)
Focus on designing health care structures and services for rare diseases. (2012) (4)
Morbidity-based risk adjustment in Germany: long in coming, but worth the wait? (2009) (4)
Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference (2021) (4)
[Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?]. (2003) (4)
[Health technology assessment in the international context: where does Germany stand? For the "German Scientific Working Group Technology Assessment for Health care"]. (1999) (4)
Lehrbuch Prävention und Gesundheitsförderung (2007) (4)
Leistungsmanagement im Gesundheitswesen — Einführung und methodische Grundlagen (2006) (3)
Collaboration between health policy and the European observatory on health systems and policies enables open access to selected policy-relevant articles. (2013) (3)
PAYMENT SYSTEMS TO IMPROVE QUALITY, EFFICIENCY, AND CARE COORDINATION FOR CHRONICALLY ILL PATIENTS – A FRAMEWORK AND COUNTRY EXAMPLES1 (2015) (3)
chapter nine Technological innovation in DRG-based hospital payment systems across Europe (2013) (3)
Der Zusammenhang zwischen Sicherheitskultur und Burnout-Risiko: Eine Befragung nicht-ärztlicher Mitarbeiter im Rettungsdienst (2020) (3)
[Endoscopic biopsy using the electrocautery snare (macro particle biopsy)]. (1975) (3)
A workplace organisational intervention to improve hospital nurses’ and physicians’ mental health: study protocol for the Magnet4Europe wait list cluster randomised controlled trial (2022) (3)
Krankenhaus: Impulse aus Dänemark für Deutschland (2018) (3)
[Teleradiological report turnaround times: An internal efficiency and quality control analysis]. (2015) (3)
Erste Erfahrungen mit der Mischung aus Kopfpauschalen, Bürgerversicherung und einem zentralen Fonds (2006) (3)
South Korea: An interesting case to study. (2016) (3)
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 (2023) (3)
[Susceptibility to strategy of the drug component of the IPHCC+RxGroups classification system in a risk-adjusted morbidity compensation scheme--a conceptional and data-supported analysis]. (2007) (3)
[Amenable mortality in Germany: spatial distribution and regional concentrations]. (2011) (3)
[Structure of hospital care for COVID-19 patients up to July 2020 in Germany]. (2021) (3)
The strongly decentralized Swiss health system achieves good results: Past research has addressed persisting challenges - but more is encouraged. (2018) (3)
Improving the Effectiveness of Health Targets (2008) (3)
Das Berliner Herzinfarktregister als Beispiel für ein klinisches Register (2012) (3)
Gender in health technology assessment: Pilot study on agency approaches (2011) (3)
Ventricular assist devices for heart failure (2007) (3)
Hausärztliche Diagnostik bei Patienten mit Venenerkrankungen in Abhängigkeit von Schweregrad, Diagnose und Praxisausstattung : Ergebnisse aus der ÄSAM-Studie Ärztliche Standort- und Faktorbeurteilung und Untersuchung des ambulanten Patientenmanagements (1996) (3)
Leistungsbewertung von deutschen Krankenhäusern (2011) (3)
Hausärztliche Betreuung und Therapie von Finalkranken--eine Längsschnittstudie. (1997) (3)
WHICH FACTORS DETERMINE THE USE OF DIAGNOSTIC IMAGING TECHNOLOGIES FOR GASTROINTESTINAL COMPLAINTS IN GENERAL MEDICAL PRACTICE? (1999) (3)
PET/PET-CT Evidenz zum Bedarf und zur Planung in Deutschland und Österreich: Update 2018 (2019) (3)
The contribution of health systems research to HSR: time to know what we are talking about, and why it is important for evidence-based policy-making (2014) (3)
Benefit Assessment and Reimbursement of Digital Health Applications: Concepts for Setting Up a New System for Public Coverage (2022) (3)
6-Month Follow Up of 8679 Hospitalized COVID-19 Patients in Germany: A Nationwide Cohort Study (2021) (3)
Effectiveness of an intensive care telehealth programme to improve process quality (ERIC): a multicentre stepped wedge cluster randomised controlled trial (2023) (3)
Poland: A large but still under-researched country. (2016) (3)
Health Workforce Mobility and Policy Responses in South East Europe (2012) (3)
Do private German health insurers invest their capital reserves of €353 billion according to environmental, social and governance criteria? (2020) (3)
Best practice in undertaking and reporting HTA. Working Group 4 Final Report (2001) (2)
Priority setting methods in health informationMM Hofmarcher (2016) (2)
[Health systems as an epidemiological topic--or how do we know how effective health systems are?]. (2006) (2)
Hospital outcomes research in Germany: results from a retrospective survey among sickness fund beneficiaries. (1997) (2)
Interferons and Natalizumab for Multiple Sclerosis (2008) (2)
QUALITY OF SAMPLE SIZE ESTIMATION IN TRIALS OF MEDICAL DEVICES: HIGH-RISK DEVICES FOR NEUROLOGICAL CONDITIONS AS EXAMPLE (2017) (2)
Scenarios on the development of consumer choice for healthcare services (2002) (2)
chapter ten Purchasing for quality of care (2006) (2)
Incidence and outcomes of SARS-CoV-2-associated PIMS in Germany: a nationwide analysis (2022) (2)
[Why do adults with mucoviscidosis refuse a medically recommended course of intravenous antibiotic therapy?]. (1997) (2)
Effects of Ownership on Hospital Efficiency in Germany – a Tobit Panel Data Approach Based on DEA Efficiency Scores (2008) (2)
Health technology assessment at age 25-Squaring the circle of strong methodology and context-dependency? (2019) (2)
Correction: Descriptive, cross-country analysis of the nurse practitioner workforce in six countries: size, growth, physician substitution potential (2016) (2)
Baseline characteristics, diagnostic efficacy, and peri-examinational safety of IV gadoteric acid MRI in 148,489 patients (2019) (2)
Digital health applications and the fast-track pathway to public health coverage in Germany: challenges and opportunities based on first results (2022) (2)
Healthcare Public Health (2020) (2)
Measuring efficiency of the German health care system from the population perspective (2020) (2)
Whose 'wish bias'? (2003) (2)
Alemania: calidad y financiación de la asistencia en crisis Germany: Quality and Funding of the Health Care in Crisis (2004) (2)
Can pharmaceutical pricing and reimbursement policies make a difference in promoting equitable access to affordable medicines? From diagnosis to sustainable impact. (2019) (2)
Bedeutung von Health Technology Assessment bei Bewertungs- und Erstattungsentscheidungen in Deutschland heute und morgen (2005) (2)
Indikatorenset der Diabetes-Surveillance (2018) (2)
Die Zukunft des deutschen Gesundheitssystems — Vorschläge, Mythen und Aussichten (1994) (2)
Ergebnisse eines systematischen Reviews zur Effektivität von Disease Management Programmen (DMPs) bei Typ 2 Diabetes mellitus in Deutschland (2014) (2)
Höhere Versorgungsqualität durch mehr Konzentration und Spezialisierung (2019) (2)
Arbeitszufriedenheit und Burnout in der präklinischen Notfallversorgung (2021) (2)
Wie bewerten chronisch Kranke die organisatorischen und interpersonellen Aspekte ihrer haus- und fachärztlichen Versorgung im Vergleich? Ergebnisse einer deutschlandweiten Befragung. (2016) (2)
Biosimilars in Deutschland und im europäischen Vergleich – Entwicklungen und Potenziale (2019) (2)
Problemorientiertes Lernen im sozialmedizinischen Kurs : ein Konzept zur Steigerung von Lernerfolg und Praxisrelevanz (1996) (2)
Messung der Patientenzufriedenheit in ambulanter haus- und fachärztlicher Behandlung: das QUALISKOPE-A (2004) (2)
Teleradiologische Prozess- und Untersuchungszeiten (2015) (2)
COVID-19 als Stresstest für das Gesundheitssystem: Eine Bestandsaufnahme der Situation in Dänemark und Deutschland (2020) (2)
Public Health Ethik: Normative Grundlagen und methodisches Vorgehen (2012) (2)
[Memorandum about preventive medicine research in Germany]. (2004) (2)
Deutsche Gesellschaft für Gesundheitsökonomie e.V. – Perspektiven einer Reform der Krankenhausfinanzierung in Deutschland (2014) (1)
Wie digitalisiert ist die Gesundheitsversorgung in Dänemark im Vergleich zu Deutschland? (2020) (1)
Focus on primary care, appropriateness and transparency, national strategies (2009) (1)
Reimbursement decisions for medical services in Austria: an analysis of influencing factors for the hospital individual services catalogue between 2008 and 2020 (2021) (1)
Health technology assessment of oral anticoagulation following heart valve replacement (2001) (1)
Übertragbarkeit neuer Versorgungsformen in die Regelversorgung (2020) (1)
Screening on urogenital Chlamydia trachomatis (2005) (1)
PHP24 A SYSTEMATIC REVIEW OF THE EUROPEAN PHARMACEUTICAL MARKET AND THE IMPACT OF EUROPEAN UNION REGULATION AND JURISDICTION (2005) (1)
Focus on long-term care, sickness funds as payers and players, improving quality of care (2008) (1)
Systemic surgery: a new social contract for health care (2001) (1)
Correction to: Implementation of innovative medical technologies in German inpatient care: patterns of utilization and evidence development (2022) (1)
Erratum to "Balancing adoption and affordability of medical devices in Europe" [Health Policy 92 (2009) 218-224] (2010) (1)
The future of pharmaceutical policy in the European Union until 2025: results of a Delphi survey (2010) (1)
[General practice management and therapy of terminally ill patients--a longitudinal study]. (1997) (1)
[Determinants for diagnostic and therapeutic co-operation between general practitioners]. (1998) (1)
[Diagnosis, therapy and prevention of lung diseases: how do we know what is effective?]. (1997) (1)
Thirteen Years of a Nation-Wide Curriculum in Medical Informatics: Does it Still Meet the Requirements? (1991) (1)
Are persons with a limited health literacy less satisfied with the German health care system? (2020) (1)
Recording early deaths following emergency department visits in inpatient data: An observational study using data of 16 German hospitals. (2023) (1)
Focus on access, primary care, health care organization (2005) (1)
Acute Appendicitis: Trends in Surgical Treatment. (2021) (1)
6-Month Follow Up of Hospitalised COVID-19 Patients: A Nationwide Cohort Study of 8679 Patients in Germany (2021) (1)
Toward System-Wide Implementation of Patient-Reported Outcome Measures: A Framework for Countries, States, and Regions. (2022) (1)
Das Arbeitsumfeld als (Qualitäts-)Indikator für Patienten- und Pflegeergebnisse (2012) (1)
120 Jahre Krankenversicherung in der deutschen Gesundheitsversorgung (2003) (1)
[Hemodiafiltration compared to hemodialysis regarding all-cause mortality and quality of life: a systematic review]. (2015) (1)
Financial risk protection of individuals with private health insurance (2020) (1)
Can competition improve hospital quality of care? A difference-in-differences approach to evaluate the effect of increasing quality transparency on hospital quality (2022) (1)
The association between experienced discrimination and forgone care among chronically ill in Germany (2015) (1)
Chronic disease management 1 Chronic disease management in Europe (2009) (1)
Evaluation von Kosteneffektivität in der Gesundheitsversorgung. (1997) (1)
Vergleich der Qualität der stationären Versorgung von Herzinfarktpatienten in Berlin auf der Basis von Routinedaten (AOK Berlin) und Daten des Berliner Herzinfarktregisters (BHIR) (2010) (1)
Public policies for disease prevention in Germany in the European context (2004) (1)
Aktuelle internationale Initiativen der evidenzbasierten Bewertung von Arzneimitteln - Implikationen für Zulassung und Health Technology Assessment in Deutschland und Europa (2011) (1)
Large register-based study of patients hospitalized with affective disorders: No support for the hypothesis that depression increases risk of cancer (2004) (1)
Utilization of Innovative Medical Technologies In German Inpatient Care: Does Evidence Matter? (2021) (1)
Ein systematischer Review zur Wirkung der EU-Regulierung auf den europäischen Arzneimittelmarkt (2005) (1)
Qualitätssicherung mit Routine- oder Primärdaten? QS-AMI Projekt zur Beurteilung der Qualität der stationären Versorgung von Herzinfarkt-PatientInnen in Berlin (laufendes Projekt) (2014) (1)
Entlastung für die Pflege? (2018) (1)
Der ältere Krebspatient - Herausforderungen im Krankenhaus und in der Praxis (2018) (1)
Gesundheitsökonomisches Zentrum Berlin (Berlin HECOR) (2013) (1)
[Endoscopy of the rectum and large intestine]. (1975) (1)
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation (2023) (1)
Zentralisierung und Spezialisierung. Dänemarks Spezialisierungspläne als strategisches Planungs- und Steuerungsinstrument am Beispiel der Krebsbehandlung (2020) (1)
Ambulante hausärztliche Versorgung von Patienten mit chronischen Schmerzen am Bewegungsapparat mit Ausnahme des Rückens (1995) (1)
Chapter 8. Being responsive to citizens' expectations: The role of health services in responsiveness and satisfaction 1 (2012) (1)
Different Spreading Dynamics Throughout Germany During the Second Wave of the COVID-19 Pandemic: Link to Public Health Interventions (2021) (1)
Versorgungsprozesse und das Zusammenspiel der Sektoren im internationalen Vergleich (2021) (1)
Überlegungen zu Validität und Vergleichbarkeit von Daten der Todesursachenstatistik, GKV Daten und Registerdaten am Beispiel Herzinfarkt (2009) (1)
Economic performance evaluation of integrated care models: comparison of methods and proposal of a pragmatic best practice model for countries with morbidity-based risk adjustment schemes (2014) (1)
Indicators for structured monitoring of health system performanceMaria M. Hofmarcher (2016) (1)
Ein einheitliches Vergütungssystem für ambulante und stationäre ärztliche Leistungen – Notwendigkeit und Entwicklung (2017) (1)
Ethische Probleme bei der Anwendung ökonomischer Instrumente zur Entscheidungsfindung in der Förderung von Gesundheitsforschung (2005) (1)
Biosimilars in Deutschland und im europäischen Vergleich – Marktsteuerungsmechanismen und Einsparpotenziale (2020) (1)
Modellierung des Kapitalwertes von Disease Management Programmen unter Anwendung der Monte-Carlo-Simulation (2006) (1)
Qualitätstransparenz im Gesundheitswesen: eine gesundheitsökonomische Modellbetrachtung (2021) (1)
[Recording Trauma Care in German Hospital Discharge Data: Services Provided by Hospitals Owned by Workers' Compensation Funds and Financed through Statutory Accidental Insurance]. (2021) (1)
Wann ist eine teure Arzneimitteltherapie preiswert? (2004) (1)
Wie rückt Qualität in den Fokus der Gesundheitsversorgung? Ergebnisse einer Delphi- und Akteurbefragung (2010) (1)
[Endoscopic polypectomy of the upper gastro-intestinal tract: results and clinical features (author's transl)]. (1975) (1)
Kapitel 22 – Denken in Zusammenhängen: Gesundheitssystemforschung (2012) (1)
PMH32 NEUROLEPTIC TREATMENT OF SCHIZOPHRENIA IN AMBULATORY CARE IN GERMANY (2005) (1)
Wie sind Ärzte gegenüber Leitlinien eingestellt (2004) (1)
Evaluation von Arzneimitteln nach der Marktzulassung: ein internationaler Vergleich (2005) (1)
Veränderungen des Krankenhausmanagements im Kontext des Wandels internationaler Ge- sundheitssysteme (2009) (1)
[Economic Evaluation of Integrated Care Systems - Scientific Standard Specifications, Challenges, Best Practice Model]. (2014) (1)
Assessing the benefit of new pharmaceuticals: Are we talking the same language, can we explain disagreement, and would it be better to do it together? (2016) (1)
Lessons learned from the COVID-19 pandemic (2022) (1)
[When is expensive pharmacotherapy good value for the money?]. (2004) (1)
[Evaluation of cost effectiveness in primary health care]. (1997) (1)
Assessment of health system performance in Germany: Survey-based insights into the perspective of people with private health insurance. (2022) (1)
Expansion of activity-based hospital payment in Israel: evaluation of effects on inpatient activity (2019) (0)
Understanding quality of care and analyzing different strategies to assure and improve it (2019) (0)
Abstracts of papers presented at the XIVth Platelet Meeting, 15-17 October 1999, Castle Oppurg, Thuringia, Germany (2000) (0)
Implementing integrated care for multi-morbidity: analysis of experiences in 17 European programmes (2019) (0)
Portable continuous wave Doppler ultrasound for primary healthcare in South Africa: can the EUnetHTA Core Model guide evaluation before technology adoption? (2020) (0)
Enhanced Recovery after Intensive Care (ERIC): study protocol for a stepped wedge cluster randomized controlled trial to evaluate the effectiveness of a critical care telehealth program on process quality and functional outcomes (2020) (0)
Health Technology Assessment in Deutschland (1998) (0)
[Histotopography of chronic gastritis in localized processes of the gastric wall and in resected stomach (author's transl)]. (1978) (0)
Health care patterns and policies in 18 European countries during the first wave of the COVID-19 pandemic: an observational study (2022) (0)
European Public Health News (2022) (0)
Erratum zu: Teleradiologische Prozess- und Untersuchungszeiten. Eine institutsinterne Effizienz- und Qualitätsanalyse (2015) (0)
Erratum to: Ginkgo biloba in Alzheimer"s disease: a systematic review (2011) (0)
Decision-Making and Priority-Setting in Public Health and Health Care in Germany (2018) (0)
Health Affairs Lessons For The United States Hospital Payment Based On Diagnosis-Related Groups Differs In Europe And Holds (2013) (0)
Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference (2021) (0)
Germany’s long-term care system– Who is eligible and what does it cost after recent major reforms? (2018) (0)
care quality : the US experience Different routes to quality improvement in Germany England : The Quality Assurance Framework Measuring the quality of long-term care (2010) (0)
The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study (2021) (0)
Piloting a Health System Performance Assessment for Germany - insights from trend and equity analyses (2022) (0)
The policy contribution of the German Health Economic Centres. (2016) (0)
It probably worked: a Bayesian approach to evaluating the introduction of activity-based hospital payment in Israel (2022) (0)
[Radiology, health care structural reform and health system research--status, developments and challenges]. (1995) (0)
Dual Agency: A Fresh Perspective to Identify Dilemma Mitigation Strategies – A Response to the Recent Commentaries (2022) (0)
References Whose 'wish Bias'? Reply to Letter to the Editor " Whose 'wish Bias'? " , By (0)
Health baskets in 9 countries of the EU. Editorial (2007) (0)
“Best Practice” in Health Care - ein europäisches Projekt (1999) (0)
Die EU und die Gesundheitswesen: (k)ein Ende des Spannungsverhältnisses in Sicht? (2007) (0)
Health systems profiles template (2005) (0)
Jahrzehnte der Transformation: Eine Analyse Dänemarks Struktur- und Krankenhausreform (2020) (0)
[On kallikrein excretion in human urine following kidney transplantation]. (1968) (0)
Gesundheitssystem – Im Blick: Gesundheitsversorgung (2014) (0)
Promoting positive masculinities among young people in Stockholm, Sweden. A mixed-methods study (2022) (0)
Patienten mit Herzinfarkt in Berlin (2016) (0)
Zukünftige Krankenhausstruktur: Was in der nächsten Legislaturperiode wirklich verändert gehört (2021) (0)
Möglichkeiten zur Abbildung von Morbidität bei PKV-Versicherten anhand von verknüpften Befragungs- und Abrechnungsdaten (Projekt IPHA) (2021) (0)
S31.1: Master of Science in Epidemiology- the first German platform for high-quality further education in Epidemiology in a network of national and foreign experts. An experience report (2004) (0)
Quality of health care in Germany: results of a pilot study to assess health system performance (2022) (0)
Gesundheitsförderung im internationalen Vergleich (2006) (0)
he impact of physician supply on avoidable cancer deaths in ermany . A spatial analysis (2011) (0)
Methodische Mindestanforderungen an die Evaluation von Disease Management Programmen (2014) (0)
Schleichender demografischer Wandel und neurologische Rehabilitation – Teil 2: Handlungsmöglichkeiten (2023) (0)
Mut zur Lücke? Die Neuorientierung in der zahnmedizinischen Versorgung und ihre Alternativen (1998) (0)
Health system efficiency in Germany: results of a pilot study to assess health system performance (2022) (0)
4 Materielle und personelle Ressourcen (2017) (0)
Denken in Zusammenhängen (2012) (0)
The association between disease management programs and health system responsivenessMiriam Blümel (2015) (0)
5 Leistungserbringung im Gesundheitssystem (2017) (0)
Implikationen der Aufhebung der Arzneimittelpreisverordnung für den Preiswettbewerb auf dem OTC-Markt (2006) (0)
Eingeschränkte Gesundheitskompetenz trotz eines hohen Bildungsniveaus? Ergebnisse einer Befragung von privat Krankenversicherten im Rahmen des Projekts IPHA (2022) (0)
When are expensive drugs good value for money (2004) (0)
Ergebnisorientierte Gesundheitsziele für Gesundheitswesen (1998) (0)
Gesundheitsversorgung — Internationale Übersicht (2006) (0)
Implizite Rationierung von Pfl egeleistungen in deutschen Akutkrankenhäusern – Ergebnisse der internationalen Pfl (2014) (0)
Neuer Finanzierungsmix (2020) (0)
Assemble key health system performance indicators and related (meta)informationMaria M. Hofmarcher (2015) (0)
Ethical problems in the implementation of economic instruments for decision making in the promotion of health research (2005) (0)
Erfassung der Verletztenversorgung in Krankenhausabrechnungsdaten: Leistungen der BG Kliniken zu Lasten der Gesetzlichen Unfallversicherung (2021) (0)
Therapieentscheidungen an der stationär-ambulanten Schnittstelle (1999) (0)
[Operative diagnostic and therapeutic endoscopy of the digestive tract (author's transl)]. (1975) (0)
Deutschland und Dänemark – verschiedene Welten? Ein umfassender Vergleich der Gesundheitssysteme (2020) (0)
Messung des Zugangs zur Gesundheitsversorgung: Ergebnisse der Pilotierung eines Health System Performance Assessments (HSPA) für Deutschland (2022) (0)
[Social health insurance for all: can we learn from Japan?]. (1997) (0)
OP-EURP220133 423..424 ++ (2022) (0)
Perception of Health System Responsiveness in Germany among patients with private health insurance (2022) (0)
Verbreitung und Strategien zur Bekämpfung chronischer Krankheiten im internationalen Vergleich (2010) (0)
Von Buchhaltern zu Versorgungsmanagern - der Aufstieg der Krankenkassen im internationalen Vergleich (2005) (0)
Piloting the first health system performance assessment for Germany: key results and learnings (2022) (0)
Vergütung und Qualität: Ziele, Anreizwirkungen, internationale Erfahrungen und Vorschläge für Deutschland (2020) (0)
Welche Anreizwirkungen hatder Morbi-RSA hinsichtlich des Leistungs- und Qualitätsmanagementsbei den Krankenkassen und Leistungserbringern? (2008) (0)
[Gastro-intestinal endoscopy - today and tomorrow (author's transl)]. (1975) (0)
Health System Performance Assessment: Does Germany provide good access to healthcare? (2022) (0)
Ermittlung von Prädiktoren zur Erklärung der Varianz stationärer Kosten bei Mukoviszidose (2005) (0)
Improving population health in Germany – lessons of a pilot study to assess health system performance (2022) (0)
Performance Assessment of German Hospitals (2011) (0)
East Asia - A look at selected health policy developments and health care assessments in universal health coverage systems. (2019) (0)
Gesundheitswesen im Wandel (1997) (0)
Krankenkassenwechsel in der GKV: Analysen zu Bereitschaft und Beweggründen anhand einer Querschnittsbefragung von GKV-Versicherten (2022) (0)
Bereitschaft zum Krankenkassenwechsel – Gruppenunterschiede und Beweggründe: eine Querschnittsbefragung von gesetzlich Versicherten (2022) (0)
Untergrenzen für Deutschland (2018) (0)
Das Projekt „Krankenhaus: Impulse für Deutschland aus Dänemark (K:IDD)“ (2020) (0)
[Out-of-Hospital and in-Hospital Death from Myocardial Infarction in Berlin]. (2020) (0)
Hospital choice matters: A 2006–2014 time-trend analysis of outcome variation in German hospitals (2016) (0)
Deutsche Gesellschaft für Gesundheitsökonomie e.V. (2022) (0)
Planung und Entwicklung von Humankapital im Gesundheitswesen – ein europäischer Vergleich (2004) (0)
[Crohn's regional enteritis. Clinical report]. (1977) (0)
4.K. Workshop: Promoting and enhancing health literacy through school interventions (2022) (0)
4.J. Workshop: Health system performance assessment in Europe – recent developments, evidence, and challenges (2022) (0)
Pilotierung eines Health System Performance Assessment (HSPA) für das deutsche Gesundheitssystem – Einblicke in Trend- und Equity-Analysen sowie zukünftige Herausforderungen (2022) (0)
Präferenzen von Patienten, pflegenden Angehörigen, Leistungserbringern, Kostenträgern und politischen Entscheidungsträgern bei der integrierten Versorgung in Deutschland: Ein Discrete Choice Experiment (2021) (0)
Herausforderungen bei der wissenschaftlichen Nutzung von Abrechnungsdaten eines privaten Krankenversicherungsunternehmens (Projekt IPHA) (2021) (0)
Der Blick über die Grenzen. Patientenpartizipation in Europa (2002) (0)
How do managers and physicians reconcile between financial and clinical considerations in hospitals? (2020) (0)
[Attempt to exclude invasive cardiology services in Poland--rationing, national sovereignty and European Union law]. (2006) (0)
HTA-Online- Erste Online-Ausbildung zum Thema Health Technology Assessment in deutscher Sprache (2010) (0)
[How to bring quality into the focus of health care--results of a delphi and stakeholder survey]. (2010) (0)
Economic Evaluation of a Mobile Stroke Unit Service in Germany (2023) (0)
GKV für alle : Können wir von Japan lernen ? (1997) (0)
Analyse der Zeitangaben in Krankenhausabrechnungsdaten bei ST-Streckenhebungs-Herzinfarkt und Linksherzkatheterintervention (2021) (0)
Kooperation und Integration von Krankenhäusern (2017) (0)
The European Parliament and public health Measuring the appropriateness of health care Cost sharing in health care Health policy in the UK eurohealth Analysing Health Targets in Europe (2017) (0)
The European Union and Health services - The Impact of the Single European Market on Member States : Summary of a Report to the European Commission (2001) (0)
6 Reformen im Gesundheitssystem (2017) (0)
European Public Health News. (2022) (0)
Outcome-orientierte Umgestaltung von Gesundheitssystemen (1998) (0)
developmentissues in funding orphan drug research and (2007) (0)
[Significance of rectoscopy as a diagnostic and therapeutic technic]. (1976) (0)
Erratum to: Spatial distribution of avoidable cancer deaths in Germany (2012) (0)
The role of sickness funds in strategic purchasing: an international comparison. (2002) (0)
7 Bewertung des Gesundheitssystems (2017) (0)
[Development of a reliable prognosis model for planning nursing care needs: registered nurse forecasting]. (2009) (0)
[Resection of non-contractile segments of the left ventricle after myocardial infarction]. (1973) (0)
Rund um Public Health: BIOMED-Projekt zur EU-Regulation von Gesundheitssystemen (1997) (0)
Neue Versorgungsformen. Ein Rahmen für gute Zusammenarbeit (2019) (0)
[Urinary excretion of kalikrein after kidney transplantation in the dog]. (1968) (0)
Geographischer Zugang zur Gesundheitsversorgung versus Patientenwahrnehmung / Geographic Access to Health Care versus Patient's Perception (2019) (0)
Focus on public-private mix, patient safety, public health (2006) (0)
Schleichender demografischer Wandel und neurologische Rehabilitation – Teil 1: Situationsbeschreibung (2022) (0)
Effizienzmessung auf Gesundheitssystemebene: Ergebnisse der Pilotierung eines Health System Performance Assessments für Deutschland (2022) (0)
Informationsmanagement und Controlling (2010) (0)
DiseaseManagement Programs In Germany’s Statutory Health Insurance System (2004) (0)
Herzinfarktsterblichkeit innerhalb und außerhalb der Kliniken in Berlin (2020) (0)
Author ’ s response to reviews Title : Evidence-based decision-making for diagnostic and therapeutic methods : the changing landscape of assessment approaches in Germany Authors : (2017) (0)
Health policies 25 years after the fall of the Iron Curtain. (2014) (0)
The contribution of health systems research to HSR (2014) (0)
Focus on continuity in care, evaluation techniques, IT for health (2006) (0)
Focus on mental health, new role for hospitals, search for the right funding mix (2008) (0)
Cost containment in Germany: twenty years experience (2019) (0)
Focus on primary care--a tribute to Barbara Starfield. (2011) (0)
PP112 Reimbursement Decisions for Medical Services in Austria: An Analysis of Influencing Factors for the Hospital Individual Services Catalogue (2022) (0)
Financial contribution of patients to health care costs in Germany - Some barely empirical evidence (2004) (0)
PET/PET-CT Evidence for need based planning in Germany and Austria (2018) (0)
Activity-based hospital payments: a qualitative evaluation by Israeli managers and physicians (2019) (0)
International Experiences in Cost-Benefit Analysis - A Review (2009) (0)
A composite measure for patient-reported outcomes in orthopedic care: design principles and validity checks. (2023) (0)
Health Services Research (2005) (0)
Health system performance assessment from the private health insured persons’ perspective in Germany (2020) (0)
Achieving Sustainability and Scale-Up of Mobile Health Noncommunicable Disease Interventions in Sub-Saharan Africa: Views of Policy Makers in Ghana (Preprint) (2018) (0)
[Slow demographic change and neurological rehabilitation-Part 1: state of affairs]. (2022) (0)
Focus on accountability, (de) centralization, information technologies (2004) (0)
Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 (2020) (0)
[Patients, Partners, Professionals, Payers and Policy Makers Preferences for Integrated Care for Multimorbidity in Germany: A Discrete Choice Experiment]. (2021) (0)
Can digitally collected PROMs as intervention for post-treatment adaption improve cost effectiveness: study protocol for a randomized controlled trial (2020) (0)
Focus on health and aging : Pharmaceutical policy and human resources (2004) (0)
Measurement of patient satisfaction in outpatient family practice and outpatient specialized practices - QUALISKOPE-A (2004) (0)
Meldung – Mitmachen bei der Untersuchung des deutschen Rettungsdienstes (2014) (0)
A systematic review of the effect of EU regulation on the European pharmaceutical market (2005) (0)
SELFIE, a novel Horizon2020 project on integrated care for multi-morbidity (2016) (0)
Drivers of patient perceptions of health system responsiveness in Germany. (2022) (0)
[Family practice diagnosis of patients with venous diseases in relation to severity, diagnosis and practice facilities. Results of the ASAM study "Physician status and factor evaluation study of ambulatory patient management"]. (1996) (0)
Insights on continuity of care in the cross-border context from a survey of German patients (2014) (0)
User clusters, click streams and barriers on Germany`s public reporting portal Weisse Liste.de (2016) (0)
Health care public reporting utilization (2017) (0)
Measuring the Triple Aim dimension “population health” in integrated care systems (ICS) using claims data – the approach of the German ICS “Gesundes Kinzigtal” (2015) (0)
Prevention policy from a European perspective (2004) (0)
A framework for a health system performance assessment for Germany: development and discussion (2018) (0)
Living up to improved performance - The role of international research projects. Results of the EuroREACH studyBritta Zander (2014) (0)
Attributes of emergency medical care from patient perspectiveCornelia Henschke (2015) (0)
"Bestandsaufnahme, Bewertung und Vorbereitung der Implementation einer Datensammlung 'Evaluation medizinischer Verfahren und Technologien' in der Bundesrepublik Deutschland" Das Mammographie-Screening zur Bruskrebsfrüherkennung (1998) (0)
Health Insurance in Moldova Procurement of medical devices in England : application to wound care Reference pricing for medical devices in Germany Financing medical devices in Italy : cardiovascular technologies Medical devices : exploiting the potential in Europe (2008) (0)
EDITORIAL DO DIAGNOSIS-RELATED GROUPS EXPLAIN VARIATIONS IN HOSPITAL COSTS AND LENGTH OF STAY? - ANALYSES FROM THE EURODRG PROJECT FOR 10 EPISODES OF CARE ACROSS (2012) (0)
Erfassung von Indikationsqualität mithilfe von GKV-Routinedaten (2022) (0)
Which incentives will the new morbidity-oriented risk structure allocation mechanism have upon the utilisation and quality management of payers and providers? (2008) (0)
Health Insurance in Germany: Benefits and reimbursement (2004) (0)
Suicidal crises in unipolar depression: How do non-drug interventions impact their management? IQWiG Reports – Commission No. HT17-03 (2020) (0)
The role of consumer choice in out-of-pocket spending on health (2023) (0)
Medizinische Informatik im Medizinstudium: Umfragen unter Studierenden und Hochschullehrern, internationale Vergleiche und Vorschläge für ein zukünftiges Curriculum (1991) (0)
Health care systems : towards an agenda for policy learning between Britain and Germany (2002) (0)
Entwicklungen in der chirurgischen Behandlung der akuten Appendizitis - Eine deutschlandweite Auswertung DRG-basierter Fallzahlen (2020) (0)
Health Services Evaluation (2019) (0)
eHealth-Entwicklungen international – Stand und Perspektiven (2011) (0)
Die Wirkung von Arzneimittelbudgets auf das Verschreibungsverhalten von niedergelassenen Ärzten in Deutschland (2004) (0)
Germany: Health System Review. (2020) (0)
Die Wahrnehmung der gesundheitlichen Versorgungssituation in Deutschland aus Sicht von privat Krankenversicherten (Projekt IPHA) (2021) (0)
Health Literacy of People with Substitutive Private Health Insurance in Germany and Their Assessment of the Health System Performance According to Health Literacy Levels: Results from a Survey (2022) (0)
[Erratum to: Teleradiological report turnaround times. An internal efficiency and quality control analysis]. (2015) (0)
OP-EURP220133 535..536 ++ (2022) (0)
Payment Systems for Hospital Specialists in 10 High-Income CountriesWilm Quentin (2015) (0)
Gavin Mooney 1943–2012 (2013) (0)
Ökonomie der Carotisendarteriektomie: Eine Kosten-Nutzwert-Analyse (1998) (0)
Dealing with chronic disease - the role of structured programmes and guidelines. (2012) (0)
Peer-Review Reports 1 2 3 4 5 6 7 The Cost-Effectiveness of Stereotactic Radiosurgery versus Surgical Resection in the Treatment of Brain Metastasis in Vietnam from the Perspective of Patients and Families (2011) (0)
Benefits of non-drug interventions for people with suicidal crises in unipolar depression (2019) (0)
[Slow demographic change and neurological rehabilitation-Part 2: what we can do]. (2023) (0)
Accounting for early death recording in acute myocardial infarction mortality indicators based on administrative data - Observational study comparing administrative data from Germany and the United States (2023) (0)
Determinanten diagnostischer und therapeutischer Kooperation von Hausärzten. (1998) (0)
The German Model : Measuring the Impact of Accountable Care Organizations on Population Health (2016) (0)
[Study assesses causes of burnout. Psychological illnesses are disproportionately frequent in the nursing field]. (2011) (0)
Classification of hospital admissions into emergency and elective care: a machine learning approach (2017) (0)
[Observations on social medicine in public health transition]. (1997) (0)
[ST-elevation Myocardial Infarction and Percutaneous Coronary Intervention: Analysis of Time Stamps in Hospital Administrative Data]. (2021) (0)

This paper list is powered by the following services:

Other Resources About Reinhard Busse

What Schools Are Affiliated With Reinhard Busse?

Reinhard Busse is affiliated with the following schools:

Reinhard Busse's Academic­Influence.com Rankings